Latest Molecular imaging Stories
New molecular imaging technique compensates for breathing and heartbeat to deliver highest-quality images of the heart A development in 4D image reconstruction compensates for blurring caused by the beating of the heart, say researchers at the Society of Nuclear Medicine's 59th Annual Meeting. The new method provides sharper-than-ever images of cardiac function to help pinpoint heart defects for better diagnoses and treatment. Cardiovascular disease is the number one killer across the...
Research finds major changes in treatment planning after neuroendocine cancer patients undergo molecular imaging with a specialized imaging probe A method of molecular imaging that pinpoints hormonally active tissues in the body could change the course of treatment for a remarkable number of neuroendocrine cancer patients, say researchers at the Society of Nuclear Medicine's 59th Annual Meeting. An investigation of a molecular imaging method used to evaluate neuroendocrine patients...
MIAMI BEACH, Fla., June 11, 2012 /PRNewswire/ -- At the Society of Nuclear Medicine's 59th Annual Meeting in Miami Beach, Fla., June 9-12, Cardinal Health today announced that it plans to open three new cyclotrons across the United States, further expanding its nationwide capability to manufacture molecular imaging drugs that aid in the early diagnosis, monitoring and treatment of cancer, neurological disorders and heart disease. Cyclotrons are critical to the manufacturing process...
SALT LAKE CITY, June 6, 2012 /PRNewswire/ -- In May 2012, BC Technical, Inc. acquired Xpert, a Molecular Imaging service company focused on systems, parts and customized service solutions out of Redmond, WA. This acquisition will expand Utah-based BC Technical's customer base and service presence in the Northwest. (Logo: http://photos.prnewswire.com/prnh/20120510/LA04560LOGO) Former Xpert CEOs Nick Cecil and Dave Baxter have over 65 years of nuclear medicine imaging experience. Both...
MOUNTAIN VIEW, Calif., June 6, 2012 /PRNewswire/ -- Based on its recent analysis of the organ-specific molecular imaging market, Frost & Sullivan recognizes Naviscan Inc. (Naviscan) with the 2012 European Frost & Sullivan Award for Product Quality Leadership for its organ-specific PET scanner. With its main application in Positron Emission Mammography (PEM), the product offers multiple benefits to the customer over competing products. Naviscan's PET scanner offers numerous...
DUBLIN, Ohio, June 6, 2012 /PRNewswire/ -- At the Society of Nuclear Medicine's 59th Annual Meeting in Miami Beach, Fla., June 9-12, visitors to the Cardinal Health booth #1221 can learn more about how the company's industry advocacy and inventive radiopharmaceutical solutions help nuclear medicine departments deliver exceptional care that leads to better outcomes for patients. The company is also inviting attendees to stop by its booth to help create a unique pushpin mural for the...
LUBBOCK, Texas, June 5, 2012 /PRNewswire/ -- Positron Corporation a leading molecular imaging healthcare company, specializing in the field of nuclear cardiology announces completion of its first strontium validation effort. In May 2012, Manhattan Isotope Technology (MIT), a Positron subsidiary, successfully processed strontium. The internal analysis of the product demonstrates it meets the Sr-82 purity specifications required for the formulation of Sr-82/Rb-82 generators. MIT has now...
CULVER CITY, Calif., June 5, 2012 /PRNewswire/ -- Sofie Biosciences, Inc., a molecular imaging company offering a comprehensive range of products from pre-clinical imaging systems to new diagnostic imaging agents ("probes"), introduces ELIXYS, the newest addition to their product pipeline. Formally debuting at this week's 2012 Society for Nuclear Medicine Annual Meeting, ELIXYS is an automated radiochemistry platform for the production of a diversity of PET probes, including [18F]FAC...
LONDON, May 29, 2012 /PRNewswire/ -- Rising disease incidence and growing awareness about health issues will boost demand for medical imaging services across Central and Eastern Europe (CEE). However, the installed base of imaging devices in the region is insufficient, especially in the high-end segment, such as magnetic resonance imaging (MRI), computed tomography (CT) and positron emission tomography (PET). At the same time, a large proportion of lower-end imaging modalities is...
TARRYTOWN, N.Y., May 24, 2012 /PRNewswire/ -- Bayer Radiology & Interventional will showcase new device technologies at the Annual Meeting of the Society of Nuclear Medicine (SNM) in Miami, June 9-13. The new technology includes enhancements to the Intego(TM) PET Infusion System, as well as developing platforms for controlled administration of molecular agents for SPECT and small animal imaging procedures. In PET, the MEDRAD Intego System is a worldwide market leader and...
